1. Home
  2. MRCY vs XENE Comparison

MRCY vs XENE Comparison

Compare MRCY & XENE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRCY
  • XENE
  • Stock Information
  • Founded
  • MRCY 1981
  • XENE 1996
  • Country
  • MRCY United States
  • XENE Canada
  • Employees
  • MRCY N/A
  • XENE N/A
  • Industry
  • MRCY
  • XENE Biotechnology: Pharmaceutical Preparations
  • Sector
  • MRCY
  • XENE Health Care
  • Exchange
  • MRCY Nasdaq
  • XENE Nasdaq
  • Market Cap
  • MRCY 2.8B
  • XENE 2.4B
  • IPO Year
  • MRCY 1998
  • XENE 2014
  • Fundamental
  • Price
  • MRCY $66.83
  • XENE $38.84
  • Analyst Decision
  • MRCY Buy
  • XENE Strong Buy
  • Analyst Count
  • MRCY 8
  • XENE 10
  • Target Price
  • MRCY $59.13
  • XENE $53.20
  • AVG Volume (30 Days)
  • MRCY 797.1K
  • XENE 1.1M
  • Earning Date
  • MRCY 08-11-2025
  • XENE 08-11-2025
  • Dividend Yield
  • MRCY N/A
  • XENE N/A
  • EPS Growth
  • MRCY N/A
  • XENE N/A
  • EPS
  • MRCY N/A
  • XENE N/A
  • Revenue
  • MRCY $912,020,000.00
  • XENE $7,500,000.00
  • Revenue This Year
  • MRCY $4.98
  • XENE N/A
  • Revenue Next Year
  • MRCY $6.95
  • XENE $253.71
  • P/E Ratio
  • MRCY N/A
  • XENE N/A
  • Revenue Growth
  • MRCY 9.19
  • XENE N/A
  • 52 Week Low
  • MRCY $32.32
  • XENE $26.74
  • 52 Week High
  • MRCY $69.95
  • XENE $46.00
  • Technical
  • Relative Strength Index (RSI)
  • MRCY 71.10
  • XENE 74.09
  • Support Level
  • MRCY $62.78
  • XENE $37.02
  • Resistance Level
  • MRCY $69.95
  • XENE $38.50
  • Average True Range (ATR)
  • MRCY 2.79
  • XENE 1.51
  • MACD
  • MRCY 0.65
  • XENE 0.37
  • Stochastic Oscillator
  • MRCY 82.75
  • XENE 89.51

About MRCY Mercury Systems Inc

Mercury Systems Inc is a commercial technology company serving the aerospace and defense industry. The company envisions, creates, and delivers secure open architecture solutions powering a broad range of mission-critical applications in challenging and demanding environments. Its Mercury Processing Platform spans the full breadth of signal processing from radio frequency front end to the human-machine interface to convert meaningful data, gathered in remote and hostile environments, into critical decisions. The company manufactures components, products, modules, and subsystems and sells to defense prime contractors, the U.S. government, original equipment manufacturers, and commercial aerospace companies. Geographically, it derives maximum revenue from the United States.

About XENE Xenon Pharmaceuticals Inc.

Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.

Share on Social Networks: